Here, knockdown of MOXD1 in GBM cells increased GRP78, subsequent PERK/eIF2α/GADD153 signaling and Ire1α/TRAF2/p-ASK1/p-JNK1/2 signaling. This evidence concerns the gene TRAF2 and glioblastoma.